{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:04:00Z","timestamp":1793361840159,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1093\/eurheartj\/ehr246","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T20:14:44Z","timestamp":1311452084000},"page":"3124-3133","source":"Crossref","is-referenced-by-count":21,"title":["Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice"],"prefix":"10.1093","volume":"33","author":[{"given":"Yulin","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaobing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ledent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,23]]},"reference":[{"key":"key\n\t\t\t\t20170515131030_EHR246C1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","year":"2005","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20170515131030_EHR246C2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"283","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20170515131030_EHR246C3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/35097089","article-title":"An endogenous cannabinoid (2-AG) is neuroprotective after brain injury","volume":"413","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170515131030_EHR246C4","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.yjmcc.2009.10.025","article-title":"Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure","volume":"48","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C5","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/S0024-3205(02)02474-8","article-title":"Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart","volume":"72","year":"2003","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170515131030_EHR246C6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.phrs.2009.04.003","article-title":"Endocannabinoids and cardiac contractile function: pathophysiological implications","volume":"60","year":"2009","journal-title":"Pharmacol Res"},{"key":"key\n\t\t\t\t20170515131030_EHR246C7","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension","volume":"110","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131030_EHR246C8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-003-0755-y","article-title":"The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression","volume":"367","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C9","doi-asserted-by":"crossref","first-page":"25196","DOI":"10.1074\/jbc.C500175200","article-title":"Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase","volume":"280","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170515131030_EHR246C10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.fjc.0000175437.87283.f2","article-title":"Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts","volume":"46","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C11","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0735-1097(01)01671-0","article-title":"Endogenous cannabinoids mediate hypotension after experimental myocardial infarction","volume":"38","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C12","doi-asserted-by":"crossref","first-page":"H1703","DOI":"10.1152\/ajpheart.00238.2001","article-title":"Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation","volume":"282","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C13","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","journal-title":"CNS Neurosci Ther"},{"key":"key\n\t\t\t\t20170515131030_EHR246C14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00210-004-1003-9","article-title":"Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system","volume":"371","year":"2005","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C15","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2006.11.025","article-title":"Review of current and investigational pharmacologic agents for acute heart failure syndromes","volume":"99","year":"2007","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.68.3.576","article-title":"A randomized prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction","volume":"68","year":"1983","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131030_EHR246C17","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJM198205133061902","article-title":"Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study","volume":"306","year":"1982","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515131030_EHR246C18","first-page":"1531","article-title":"Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","author":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF)","year":"2002","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515131030_EHR246C19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2010.06.023","article-title":"Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture","volume":"1348","year":"2010","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20170515131030_EHR246C20","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.lfs.2007.08.042","article-title":"Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts","volume":"81","year":"2007","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170515131030_EHR246C21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.bjp.0703902","article-title":"Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide","volume":"132","year":"2001","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S1464793103006201","article-title":"Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling","volume":"79","year":"2004","journal-title":"Biol Rev Camb Philos Soc"},{"key":"key\n\t\t\t\t20170515131030_EHR246C23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0705156","article-title":"CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction","volume":"138","year":"2003","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","year":"2005","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170515131030_EHR246C25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0008-6363(02)00268-7","article-title":"Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts","volume":"55","year":"2002","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170515131030_EHR246C26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/FJC.0b013e318192671d","article-title":"Endocannabinoids and the heart","volume":"53","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/01.fjc.0000211752.08949.eb","article-title":"2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts","volume":"47","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2007.03.057","article-title":"Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity","volume":"50","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C29","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170515131030_EHR246C30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515131030_EHR246C31","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.bjp.0704379","article-title":"Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats","volume":"134","year":"2001","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C32","doi-asserted-by":"crossref","first-page":"H1689","DOI":"10.1152\/ajpheart.00538.2007","article-title":"Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats","volume":"293","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/cvr\/cvp369","article-title":"CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes","volume":"85","year":"2010","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170515131030_EHR246C34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00395-009-0034-2","article-title":"The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction","volume":"104","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"key\n\t\t\t\t20170515131030_EHR246C35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(10)60935-X","article-title":"Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial","volume":"376","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170515131030_EHR246C36","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1001\/jama.2009.1657","article-title":"Reconsidering the role for digoxin in the management of acute heart failure syndromes","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170515131030_EHR246C37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","article-title":"Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology","volume":"26","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20170515131030_EHR246C38","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cvr\/cvr034","article-title":"AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure","volume":"90","year":"2011","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170515131030_EHR246C39","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","article-title":"Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase","volume":"119","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20170515131030_EHR246C40","first-page":"771","article-title":"The endocannabinoid system and its therapeutic exploitation","volume":"3","year":"2004","journal-title":"Nat Rev"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/33\/24\/3124\/17050396\/ehr246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T06:49:06Z","timestamp":1503557346000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehr246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,23]]},"references-count":40,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2011,7,23]]},"published-print":{"date-parts":[[2012,12]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehr246","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,23]]}}}